Preclinical pharmacology of alogabat: a novel GABA<sub>A</sub>-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA<sub>A</sub> signaling.
- DOI
- 10.3389/fphar.2025.1626078
- Published
- 2025-07-21
- Container
- Front Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2025.1626078,
title = {Preclinical pharmacology of alogabat: a novel GABA\<sub\>A\</sub\>-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA\<sub\>A\</sub\> signaling.},
author = {Cecere G and Ballard TM and Knoflach F and Honer M and Hipp JF and Garces P and Mueggler T and Künnecke B and Bruns A and Prinssen EP and Schoenenberger P and Janz P and Redondo R and Biemans B and Knust H and Olivares-Morales A and Brigo A and Schulz JM and Bertrand D and Saxe M and O'Connor EC and Hernandez MC.},
year = {2025},
journal = {Front Pharmacol},
doi = {10.3389/fphar.2025.1626078},
url = {https://doi.org/10.3389/fphar.2025.1626078}
}RIS
TY - JOUR TI - Preclinical pharmacology of alogabat: a novel GABA<sub>A</sub>-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA<sub>A</sub> signaling. AU - Cecere G AU - Ballard TM AU - Knoflach F AU - Honer M AU - Hipp JF AU - Garces P AU - Mueggler T AU - Künnecke B AU - Bruns A AU - Prinssen EP AU - Schoenenberger P AU - Janz P AU - Redondo R AU - Biemans B AU - Knust H AU - Olivares-Morales A AU - Brigo A AU - Schulz JM AU - Bertrand D AU - Saxe M AU - O'Connor EC AU - Hernandez MC. PY - 2025 JO - Front Pharmacol DO - 10.3389/fphar.2025.1626078 UR - https://doi.org/10.3389/fphar.2025.1626078 ER -
APA
G, C., TM, B., F, K., M, H., JF, H., P, G., T, M., B, K., A, B., EP, P., P, S., P, J., R, R., B, B., H, K., A, O., A, B., JM, S., D, B., M, S., EC, O., & MC., H. (2025). Preclinical pharmacology of alogabat: a novel GABA<sub>A</sub>-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABA<sub>A</sub> signaling.. Front Pharmacol. https://doi.org/10.3389/fphar.2025.1626078
Source records
- europe-pmc · retrieved 2026-09-26T09:14:08.826Z
- doaj · retrieved 2026-09-26T09:14:08.809Z